Current practices and perceptions among clinicians in osteoarthritis and osteoporosis management in Indian settings
DOI:
https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20252641Keywords:
NSAIDs, Osteoarthritis, Osteoporosis, Patient awareness, Risk factors, Treatment complianceAbstract
Background: Although there were several clinical studies available, there was a dearth of studies among clinicians in actual practice. So, the present study aimed to assess clinician perspectives on the prevalence, risk factors, diagnosis and management practices of osteoarthritis (OA) and osteoporosis (OP) in routine clinical settings, to identify gaps in awareness, treatment approaches and patient compliance.
Methods: The cross-sectional study utilized a 23-item questionnaire to gather expert insights on the management of OA and OP in Indian settings. It explored various aspects, including epidemiology, risk factors, diagnostic practices, treatment preferences and challenges in current management. The collected data were analysed using descriptive statistics.
Results: The study included 119 experts and nearly 75% of them identified knee OA as the most prevalent form of the condition. For the early management of OA, around 88% of respondents preferred a combination of nonsteroidal anti-inflammatory drugs (NSAIDs), physiotherapy, dietary modifications and exercise. Nearly 83% recognized family history, smoking, poor diet, advancing age and post-menopausal status as common risk factors for OP. Regarding screening practices, 55% of participants reported that blood tests, bone turnover markers and bone mineral density (BMD) assessments via ultrasound are the most commonly used methods. Around 77% believed that calcitriol supports fracture management, offers the benefit of weekly dosing for better compliance and is effective in treating OP. A majority (84.87%) of participants agreed that calcium aspartate is a well-tolerated and effective calcium supplement suitable for individuals across all age groups.
Conclusions: This study indicates that knee OA is the most commonly observed form, with early management favouring NSAIDs, physiotherapy, dietary modifications and exercise. In OP, lack of awareness remains a key treatment gap, while calcium aspartate and calcitriol are widely regarded as effective and well-tolerated options.
Metrics
References
Im GI, Kim MK. The relationship between osteoarthritis and osteoporosis. J Bone Miner Metab. 2014;32(2):101–9. DOI: https://doi.org/10.1007/s00774-013-0531-0
Hunter DJ, March L, Chew M. Osteoarthritis in 2020 and beyond: a Lancet Commission. Lancet. 2020;396(10264):1711–2. DOI: https://doi.org/10.1016/S0140-6736(20)32230-3
Zhu Z, Yu P, Wu Y, Wu Y, Tan Z, Ling J, et al. Sex Specific Global Burden of Osteoporosis in 204 Countries and Territories, from 1990 to 2030: An Age-Period-Cohort Modeling Study. J Nutr Health Aging. 2023;27(9):767–74. DOI: https://doi.org/10.1007/s12603-023-1971-4
Hinda R, Valecha S, Kumar N, Walia JPS, Singh K, Sethi S, et al. Prevalence and Predictors of Osteoporosis and Osteopenia in Postmenopausal Women of Punjab, India. Int J Environ Res Public Health. 2022;19(5):2999. DOI: https://doi.org/10.3390/ijerph19052999
Singh A, Das S, Chopra A, Danda D, Paul BJ, March L, et al. Burden of osteoarthritis in India and its states, 1990–2019: findings from the Global Burden of disease study 2019. Osteoarthritis and Cartilage. 2022;30(8):1070–8. DOI: https://doi.org/10.1016/j.joca.2022.05.004
Marshall DA, Liu X, Barnabe C, Yee K, Faris PD, Barber C, et al. Existing comorbidities in people with osteoarthritis: a retrospective analysis of a population-based cohort in Alberta, Canada. BMJ Open. 2019;21;9(11):33334. DOI: https://doi.org/10.1136/bmjopen-2019-033334
Kraus VB, Sun S, Reed A, Soderblom EJ, Moseley MA, Zhou K, et al. An osteoarthritis pathophysiological continuum revealed by molecular biomarkers. Sci Adv. 2022;10(17):6814. DOI: https://doi.org/10.1126/sciadv.adj6814
Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013;21(3):201–32. DOI: https://doi.org/10.1007/s10787-013-0172-x
Anderson BJ. Paracetamol (Acetaminophen): mechanisms of action. Pediatric Anesthesia. 2008;18(10):915–21. DOI: https://doi.org/10.1111/j.1460-9592.2008.02764.x
Dhesi M, Maldonado KA, Patel P, Maani CV. Tramadol. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.
Husic S, Izic S, Matic S, Sukalo A. Efficacy and Safety of a Fixed Combination of Tramadol and Paracetamol (Acetaminophen) as Pain Therapy Within Palliative Medicine. Mater Sociomed. 2015;27(1):42–7. DOI: https://doi.org/10.5455/msm.2014.27.42-47
Tang IF, Liu H, Wang Q, Bai XS, Lou T. Effects of Calcium Aspartate Anhydrous on Treatment of Osteoporosis. Available at: https.ezorbcalcium.com.
Desai HA, Shah RB, Shah H, Thakkar K. Prevalence and medicinal practices for osteoarthritis in Western India. Natl J Physiol Pharm Pharmacol. 2021;11(1):78-83. DOI: https://doi.org/10.5455/njppp.2021.11.10289202006112020
LeBoff MS, Greenspan SL, Insogna KL, Lewiecki EM, Saag KG, Singer AJ, et al. The clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022;33(10):2049–102. DOI: https://doi.org/10.1007/s00198-021-05900-y
Primorac D, Molnar V, Rod E, Jeleč Ž, Čukelj F, Matišić V, et al. Knee Osteoarthritis: A Review of Pathogenesis and State-Of-The-Art Non-Operative Therapeutic Considerations. Genes. 2020;11(8):854. DOI: https://doi.org/10.3390/genes11080854
Tong L, Yu H, Huang X, Shen J, Xiao G, Chen L, et al. Current understanding of osteoarthritis pathogenesis and relevant new approaches. Bone Res. 2022;20;10(1):1–17. DOI: https://doi.org/10.1038/s41413-022-00226-9
Ilias I, Milionis C, Zoumakis E. An overview of glucocorticoid-induced osteoporosis. Endotext. 2022.
Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med. 1998;339(5):292-9. DOI: https://doi.org/10.1056/NEJM199807303390502
Richard MJ, Driban JB, McAlindon TE. Pharmaceutical treatment of osteoarthritis. Osteoarthritis and Cartilage. 2023;31(4):458–66. DOI: https://doi.org/10.1016/j.joca.2022.11.005
Wang W, Niu Y, Jia Q. Physical therapy as a promising treatment for osteoarthritis: A narrative review. Front Physiol. 2022;13:1011407. DOI: https://doi.org/10.3389/fphys.2022.1011407
Thomas S, Browne H, Mobasheri A, Rayman MP. What is the evidence for a role for diet and nutrition in osteoarthritis. Rheumatology (Oxford). 2018;57(4):61–74. DOI: https://doi.org/10.1093/rheumatology/key011
Ratajczak AE, Szymczak-Tomczak A, Rychter AM, Zawada A, Dobrowolska A, Krela-Kaźmierczak I. Impact of cigarette smoking on the risk of osteoporosis in inflammatory bowel diseases. J Clin Med. 2021;10(7):1515. DOI: https://doi.org/10.3390/jcm10071515
de Villiers TJ. Bone health and menopause: Osteoporosis prevention and treatment. Best Pract Res Clin Endocrinol Metab. 2024;38(1):101782. DOI: https://doi.org/10.1016/j.beem.2023.101782
Inui A, Nishimoto H, Mifune Y, Yoshikawa T, Shinohara I, Furukawa T, et al. Screening for osteoporosis from blood test data in elderly women using a machine learning approach. Bioengineering. 2023;10(3):277. DOI: https://doi.org/10.3390/bioengineering10030277
Yen CC, Lin WC, Wang TH, Chen GF, Chou DY, Lin DM, et al. Pre-screening for osteoporosis with calcaneus quantitative ultrasound and dual-energy X-ray absorptiometry bone density. Sci Rep. 20213;11(1):15709. DOI: https://doi.org/10.1038/s41598-021-95261-7
Ayub N, Faraj M, Ghatan S, Reijers JAA, Napoli N, Oei L. The Treatment Gap in Osteoporosis. J Clin Med. 2021;10(13):3002. DOI: https://doi.org/10.3390/jcm10133002
Kanis JA, Svedbom A, Harvey N, McCloskey EV. The Osteoporosis Treatment Gap. J Bone Mineral Res. 2014;29(9):1926–8. DOI: https://doi.org/10.1002/jbmr.2301
Tilyard MW, Spears GF, Thomson J, Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med. 1992;326(6):357–62. DOI: https://doi.org/10.1056/NEJM199202063260601
Peppone LJ, Ling M, Huston AJ, Reid ME, Janelsins MC, Puzas JE, et al. The Effects of High-dose Calcitriol and Individualized Exercise on Bone Metabolism in Breast Cancer Survivors on Hormonal Therapy: A Phase II Feasibility Trial. Support Care Cancer. 2018;26(8):2675–83. DOI: https://doi.org/10.1007/s00520-018-4094-4
Manjula S, Krishna Kumar M. Expert opinion on the clinical use of calcium and vitamin D supplements in osteoporosis in Indian settings. Int J Res Orthopaed. 2024;10(2):364–8. DOI: https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20240420